Health Care & Life Sciences » Biotechnology | MultiCell Technologies Inc.

MultiCell Technologies Inc. | Income Statement

Fiscal year is December-November. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
98.90
49.30
49.30
49.30
49.30
SG&A Expense
1,868.90
2,360.10
1,624.20
1,417.30
772.10
EBIT
1,774.70
2,311.90
1,574.90
1,368.00
722.80
Unusual Expense
97.60
78.50
222.20
1.10
204.70
Non Operating Income/Expense
430.30
303.10
1.50
-
-
Interest Expense
42.60
23.60
8.10
2.70
10.80
Pretax Income
1,289.30
1,952.10
1,358.60
1,369.40
528.80
Consolidated Net Income
1,289.30
1,952.10
1,358.60
1,369.40
528.80
Net Income
1,166.90
1,800.70
1,256.30
1,234.60
380.10
Net Income After Extraordinaries
1,166.90
1,800.70
1,256.30
1,234.60
380.10
Net Income Available to Common
1,298.50
1,800.70
1,256.30
1,234.60
380.10
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
Basic Shares Outstanding
379,787.90
692,921.70
1,035,175.00
1,915,730.10
3,726,161.10
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
379,787.90
692,921.70
1,035,175.00
1,915,730.10
3,726,161.10
EBITDA
1,770.10
2,310.80
1,574.90
1,368.00
722.80
Non-Operating Interest Income
0.20
1.80
0.70
0.20
0.10
Minority Interest Expense
122.30
151.40
102.40
134.80
148.80
Preferred Dividends
131.50
-
-
-
-

About MultiCell Technologies

View Profile
Address
68 Cumberland Street
Woonsocket Rhode Island 02895
United States
Employees -
Website http://www.multicelltech.com
Updated 07/08/2019
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company was founded on April 28, 1970 and is headquartered in Woonsocket, RI.